SavedAdd your journal

Journals / Ege Pediatri Bülteni / 2007 / Cilt: 14 - Sayı: 1

Inflammatory bowel diseases in childhood

Çocukluk çağı inflamatuar barsak hastalığı

Gökhan TÜMGÖR
Raşit Vural YAĞCI
Çiğdem ARIKAN
Pages
63–78
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this review we delineate the clinical manifestations, diagnostic features and treatment of IBD.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Inflammatory bowel diseases (IBD), Crohn's disease and ulcerative colitis, are recognized as important causes of gastrointestinal disease in children and adults.
📊
Key Findings & Data:During the last 20 years, significant advances have been made in the area of genetics, gut ecology, immune mechanisms, and biologic therapies, yet, at present, the etiology and pathogenesis of IBD still remain to be clearly defined.
💡
Conclusion & Impact:In this review we delineate the clinical manifestations, diagnostic features and treatment of IBD.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Inflammatory bowel diseases (IBD), Crohn's disease and ulcerative colitis, are recognized as important causes of gastrointestinal disease in children and adults. During the last 20 years, significant advances have been made in the area of genetics, gut ecology, immune mechanisms, and biologic therapies, yet, at present, the etiology and pathogenesis of IBD still remain to be clearly defined. In this review we delineate the clinical manifestations, diagnostic features and treatment of IBD.

Özet

İnflamatuar barsak hastalığı, Crohn hastalığı ve Ülseratif kolit, çocuk ve erişkinlerde gastrointestinal sistem hastalıklarının önemli bir nedenidir. Son 20 yılda genetik, barsak ekolojisi, immün mekanizmalar ve biyolojik tedavi alanlarında gelişmelere rağmen İBH’nın etiyolojisi ve patogenezi hala tam olarak açıklığa kavuşmamıştır. Bu yazıda İBH’nın kliniği, tanısal özellikleri ve tedavisinin üzerinde durulmuştur.

🔖

Cite This Article

TÜMGÖR, G., YAĞCI, R. V., ARIKAN, Ç. (2022). Inflammatory bowel diseases in childhood. Ege Pediatri Bülteni, Cilt: 14 - Sayı: 1, 63–78. https://ajindex.com/articles/495706

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Hyams JS. Inflammatory bowel disease. In: Wyllie R, Hyams JS (eds). Pediatric Gastrointestinal Disease. 2nd ed. W.B Saunders Philadelphia, 1999: 213-221
  2. Oliva-Hemker M, Fiocchi C. Etiopathogenesis of inflammatory bowel disease: The importance of the pediatric perspective. Inflamm Bowel Dis 2002; 8(2): 112-28
  3. Russel MG, Stockbrugger RW. Epidemiology of inflammatory bowel disease: an update. Scand J Gastroenterol 1996; 31: 427
  4. Lindberg E, Lindquist B, Holmquist L, et al. Inflammatory bowel disease in children and adolescents in Sweden, 1984–1995. J Pediatr Gastroenterol Nutr 2000; 30: 269–74
  5. Polito JM, Childs B, Mellis ED, et al. Crohn's disease: influence of age at diagnosis on site and clinical type of disease. Gastroenterology 1996; 111: 580–6
  6. Ogura Y, Bonen DK, Inohara N, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001; 411: 603–6
  7. Hugot JP, Chamaillard M, Zouali H, et al. Associate of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001; 411: 599–603
  8. Hollander D, Vadheim CM, Brettholtz E, et al. Increased intestinal permeability in patients with Crohn's disease and their relatives. A possible etiologic factor. Ann Intern Med 1986; 105: 883–5
  9. Miki K, Moore DJ, Butler RN, et al. The sugar permeability test reflects disease activity in children and adolescents with inflammatory bowel disease. J Pediatr 1998; 133: 750–4
  10. Andres PG, Friedman LS. Epidemiology and the natural course of inflammatory bowel disease. Gastroenterol Clin North Am 1999; 28: 255–81
  11. Andus T, Gross V. Etiology and pathophysiology of inflammatory bowel disease—environmental factors. Hepatogastroenterology 2000; 47: 29–43
  12. Calkins BM. A meta-analysis of the role of smoking in inflammatory bowel disease. Dig Dis Sci 1989; 34: 1841–4
  13. Sandler RS, Sandler DP, McDonnell CW, et al. Childhood exposure to environmental tobacco smoke and the risk of ulcerative colitis. Am J Epidemiol 1992; 135: 603–8
  14. Lashner BA, Shaheen NJ, Hanauer SB, et al. Passive smoking is associated with an increased risk of developing inflammatory bowel disease in children. Am J Gastroenterol 1993; 88: 356–9
  15. Godet PG May GR, Sutherland LR. Meta-analysis of the role of oral contraceptive agents in inflammatory bowel disease. Gut 1995; 37: 668–73
  16. Mizoguchi A, Mizoguchi E, Chiba C, et al. Role of appendix in the development of inflammatory bowel disease in TCR-alpha mutant mice